Local anesthetics induce a decrease in the levels of glucose 1,6- bisphosphate, fructose 1,6-bisphosphate, and ATP, and in the viability of melanoma cells

Molecular Genetics and Metabolism

Volumn 69, Issue 1, 2000, Pages 40-45

  Karniel, Malka ^a   Beitner, Rivka ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

ATP; Bupivacaine; Fructose 1,6 bisphosphate; Glucose 1,6 bisphosphate; Glycolysis; Lidocaine; Local anesthetics; Melanoma

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIFONAZOLE; BUPIVACAINE; CALMODULIN INHIBITOR; CLOTRIMAZOLE; FRUCTOSE 1,6 BISPHOSPHATE; GLUCOSE 1,6 BISPHOSPHATE; LIDOCAINE;

ALLOSTERISM; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL DEATH; CELL VIABILITY; DOSE RESPONSE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LOCAL ANESTHESIA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

EID: 0033963030     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2954     Document Type: Article

References (36)

1. Eigenbrodt E, Fister P, Reinacher M. New perspectives on carbohydrate metabolism in tumor cells. Beitner R. Regulation of Carbohydrate Metabolism. 1985;141-179 CRC Press, Boca Raton.
2. Fiechter A, Gmünder F K. Metabolic control of glucose degradation in yeast and tumor cells. Adv Biochem Eng Biotechnol. 39:1989;1-28.
3. Beckner M E, Stracke M L, Liotta L A, Schiffmann E. Glycolysis as primary energy source in tumor cell chemotaxis. J Natl Cancer Inst. 82:1990;1836-1840.
4. Greiner E F, Guppy M, Brand K. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J Biol Chem. 269:1994;31484-31490.
5. Beitner R. The role of glucose-1,6-diphosphate in the regulation of carbohydrate metabolism in muscle. Trends Biochem Sci. 4:1979;228-230.
6. Beitner R. Control of levels of glucose 1,6-bisphosphate. Int J Biochem. 16:1984;579-585.
7. Beitner R. Glucose 1,6-bisphosphate - The regulator of carbohydrate metabolism. Beitner R. Regulation of Carbohydrate Metabolism. 1985;1-27 CRC Press, Boca Raton.
8. Beitner R. Regulation of carbohydrate metabolism by glucose-1,6-bisphosphate in extrahepatic tissues; comparison with fructose-2,6-bisphosphate. Int J Biochem. 22:1990;553-557.
9. 2+ and calmodulin. Int J Biochem. 25:1993;297-305.
10. Beitner R. Calmodulin antagonists and cell energy metabolism in health and disease. Mol Genet Metab. 64:1998;161-168.
11. Glass-Marmor L, Morgenstern H, Beitner R. Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells. Eur J Pharmacol. 313:1996;265-271.
12. Glass-Marmor L, Beitner R. Detachment of glycolytic enzymes from cytoskeleton of melanoma cells induced by calmodulin antagonists. Eur J Pharmacol. 328:1997;241-248.
13. Penso J, Beitner R. Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells. Eur J Pharmacol. 342:1998;113-117.
14. Glass-Marmor L, Beitner R. Taxol (paclitaxel) induces a detachment of phosphofructokinase from cytoskeleton of melanoma cells and decreases the levels of glucose 1,6-bisphosphate, fructose 1,6-bisphosphate and ATP. Eur J Pharmacol. 370:1999;195-199.
15. Nordenberg J, Klein S, Beery E, Kaplansky M, Beitner R. Changes in the levels of glucose 1,6-diphosphate and ATP and in the activities of phosphofructokinase and phosphoglucomutase induced by local anesthetics in the isolated rat diaphragm muscle. Int J Biochem. 13:1981;1005-1009.
16. 2+-ionophore A23187 and lithium, on glucose-1,6-bisphosphate levels and the activities of phosphofructokinase and phosphoglucomutase in rat muscle. Biochem Med Metab Biol. 38:1987;278-291.
17. Hofer H W, Pette D. Wirkungen and Wechselwirkungen von Substraten und Effektoren an der Phosphofructokinase des Kaninchen-Skeletmuskels. Hoppe-Seyler's Z Physiol Chem. 349:1968;1378-1392.
18. Beitner R, Haberman S, Nordenberg J, Cohen T J. The levels of cyclic GMP and glucose-1,6-diphosphate, and the activity of phosphofructokinase, in muscle from normal and dystrophic mice. Biochim Biophys Acta. 542:1978;537-541.
19. Beitner R, Nordenberg J. The regulatory role of glucose-1,6-diphosphate in muscle of dystrophic mice. FEBS Lett. 98:1979;199-202.
20. Passonneau J V, Lowry O H, Schulz D W, Brown J G. Glucose 1,6-diphosphate formation by phosphoglucomutase in mammalian tissues. J Biol Chem. 244:1969;902-909.
21. Lowry O H, Passonneau J V, Hasselberger F X, Schulz D W. Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J Biol Chem. 239:1964;18-30.
22. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 72:1976;248-254.
23. Floridi A, Barbieri R, Pulselli R, Fanciulli M, Arcuri E. Effect of the local anesthetic bupivacaine on the energy metabolism of Ehrlich ascites tumor cells. Oncol Res. 6:1994;593-601.
24. Gots R E, Gorin F A, Bessman S P. Kinetic enhancement of bound hexokinase activity by mitochondrial respiration. Biochem Biophys Res Commun. 49:1972;1249-1255.
25. Gots R E, Bessman S P. The functional compartmentation of mitochondrial hexokinase. Arch Biochem Biophys. 163:1974;7-14.
26. Viitanen P V, Geiger P J, Erickson-Viitanen S, Bessman S P. Evidence for functional hexokinase compartmentation in rat skeletal muscle mitochondria. J Biol Chem. 259:1984;9679-9684.
27. 2+ transport. Biochim Biophys Acta. 935:1988;87-102.
28. Wilson J E. Regulation of mammalian hexokinase activity. Beitner R. Regulation of Carbohydrate Metabolism. 1985;45-85 CRC Press, Boca Raton.
29. Adams V, Griffin L, Towbin J, Gelb B, Worley K, McCabe E RB. Porin interaction with hexokinase and glycerol kinase: Metabolic microcompartmentation at the outer mitochondrial membrane. Biochem Med Metab Biol. 45:1991;271-291.
30. Sztark F, Tueux O, Erny P, Dabadie P, Mazat J P. Effects of bupivacaine on cellular oxygen consumption and adenine nucleotide metabolism. Anesth Analg. 78:1994;335-339.
31. Grouselle M, Tueux O, Dabadie P, Georgescaud D, Mazat J P. Effect of local anaesthetics on mitochondrial membrane potential in living cells. Biochem J. 271:1990;269-272.
32. Pulselli R, Arcuri E, Paggi M G, Floridi A. Changes in membrane potential induced by local anesthetic bupivacaine on mitochondria within Ehrlich ascites tumor cells. Oncol Res. 8:1996;267-271.
33. Gold M S, Reichling D B, Hampl K F, Drasner K, Levine J D. Lidocaine toxicity in primary afferent neurons from the rat. J Pharmacol Exp Ther. 285:1998;413-421.
34. 2+-induced changes in energy metabolism and viability of melanoma cells. Br J Cancer. 81:1999;219-224.
35. 2+ ionophore A23187 and calmodulin antagonists on regulatory mechanisms of glycolysis and cell viability of NIH-3T3 fibroblasts. Mol Genet Metab. 67:1999;334-342.
36. Martinsson T, Haegerstrand A, Dalsgaard C J. Ropivacaine and lidocaine inhibit proliferation of non-transformed cultured adult human fibroblasts, endothelial cells and keratinocytes. Agents Action. 40:1993;78-85.